CARLSBAD, Calif. , March 1, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a panel discussion on orphan neurological disease therapeutics at the virtual Cowen 42 nd Annual Health Care Conference at 9:10 a.m.
Read more